Nomogram for Predicting Risk of Cancer Therapy–Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Background Cancer therapy–related cardiac dysfunction (CTRCD) is an important treatment‐limiting toxicity for patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer that adversely affects cancer and cardiovascular outcomes. Easy‐to‐use tools that incorporate readily acc...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2023-10-01
|
| Seri Bilgileri: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Konular: | |
| Online Erişim: | https://www.ahajournals.org/doi/10.1161/JAHA.123.029465 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|